Stockreport

ImmunityBio, Novo, Moderna among winners of EU drug recommendations this week [Seeking Alpha]

ImmunityBio, Inc.  (IBRX) 
PDF for approval this week, including a cancer drug from ImmunityBio ( IBRX ), a high-dose version of Novo's ( NVO ) obesity drug, Wegovy, and Moderna's ( Quick Insights [Read more]